title: Different abilities of Friend murine leukemia virus (MuLV) and Moloney MuLV to induce promonocytic leukemia are due to determinants in both psi-gag-PR and env regions.
abstract: Moloney murine leukemia virus (M-MuLV) is capable of inducing promonocytic leukemia in 50% of adult BALB/c mice that have received peritoneal injections of pristane, but Friend MuLV strain 57 (F-MuLV) is nonleukemogenic under similar conditions. It was shown earlier that these differences could not be mapped to the U3 region of the virus long terminal repeat, indicating the probable influence of structural genes and/or R-U5 sequences. In this study, reciprocal chimeras containing exchanged structural genes and R-U5 sequences from these two closely related viruses were analyzed for differences in ability to induce disease. Results showed that two regions of F-MuLV, psi-gag-PR and env, when substituted for those of M-MuLV were dramatically disease attenuating. The 5'-most region, which is widely distributed, overlaps with the 5' end of the env intron and includes the RNA packaging region, psi, the entire gag coding region, and the viral protease coding region (PR) of pol. It was also found that reciprocal constructs having substitutions of both of these regions of M-MuLV in an F-MuLV background allowed full reestablishment of promonocytic leukemia. These leukemias were positive for c-myb rearrangements which are characteristic of M-MuLV-induced promonocytic leukemias. Neither region alone, however, was sufficient to produce disease with a greater incidence than 13%. Further studies demonstrated that the inability of viruses with psi, gag, PR, or env sequences from F-MuLV to induce leukemia in this model system was not due to their inability to replicate in hematopoietic tissue, to integrate into the c-myb locus early on after infection in vivo, or to express gag-myb mRNA characteristic of M-MuLV-induced preleukemic cells and acute leukemia.
authors.affiliation: Laboratory of Genetics, National Cancer Institute, Bethesda, Maryland 20892.
authors.forename: R
authors.initials: R
authors.lastname: Mukhopadhyaya
authors.forename: J
authors.initials: J
authors.lastname: Richardson
authors.forename: V
authors.initials: V
authors.lastname: Nazarov
authors.forename: A
authors.initials: A
authors.lastname: Corbin
authors.forename: R
authors.initials: R
authors.lastname: Koller
authors.forename: M
authors.initials: M
authors.lastname: Sitbon
authors.forename: L
authors.initials: L
authors.lastname: Wolff
mesh_terms: D016475:3T3 Cells; D000818:Animals; D001483:Base Sequence; D004279:DNA, Viral; D000939:Epitopes; D005260:Female; D005622:Friend murine leukemia virus / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity*; D015683:Gene Products, gag / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D009052:Leukemia Virus, Murine / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity*; D007951:Leukemia, Myeloid / Q000382:microbiology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D016254:Mutagenesis, Insertional; D011230:Precancerous Conditions / Q000382:microbiology; D014412:Tumor Virus Infections / Q000382:microbiology*; D014759:Viral Envelope Proteins / Q000235:genetics / Q000276:immunology / Q000502:physiology*
chemical_list: D004279:DNA, Viral; D000939:Epitopes; D015683:Gene Products, gag; D014759:Viral Envelope Proteins